Abbott's MitraClip Climbs EVEREST II: What Patients Are On The Other Side?

Abbott's minimally invasive MitraClip device has the potential to control up to a $400 million worldwide market in the mitral valve repair space, analysts say, but questions remain on how the largely positive pivotal data reported last week will translate into market adoption